Belgium· BE-AMP-SAM502497-00
Odefsey 200 mg - 25 mg - 25 mg
A emtricitabine, tenofovir alafenamide and rilpivirine product containing emtricitabine, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide and rilpivirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR19 (emtricitabine, tenofovir alafenamide and rilpivirine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide and rilpivirine · ATC J05AR19
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Emtricitabine
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Belgium (BE)
- ATC code
- J05AR19
- ATC class
- Emtricitabine, tenofovir alafenamide and rilpivirine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 6
3 priced- be_apb3460755EUR 789.91
- be_apb4231445EUR 789.91
- be_apb7717598
- be_apb7729882
- be_apb7728603
- be_apb4201901EUR 789.91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide and rilpivirine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandEmtricitabine/Tenofovir alafenamide Viatris 200 mg/10 mg film-coated tabletsViatris Limited
- United StatesemtricitabineCipla USA Inc.
- CzechiaEMTRIVAGilead Sciences Ireland UC, Carrigtohill
- FinlandEmtrivaGilead Sciences Ireland UC
- United KingdomEmtriva 10mg/ml oral solutionGilead Sciences Ltd
- NetherlandsEmtriva 10 mg/ml, drankGilead Sciences Ireland UC
- IcelandEmtrivaGilead Sciences Ireland UC*
- SpainEMTRIVA 10 MG/ML SOLUCION ORALGilead Sciences Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
- Iceland · Emtriva
- Liechtenstein · Emtriva
- Norway · Emtriva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0b067ce-ea42-4ede-b114-8ecce9be0f0b GET /v1/drugs/d0b067ce-ea42-4ede-b114-8ecce9be0f0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Odefsey 200 mg - 25 mg - 25 mg",
"name_fr": "Odefsey 200 mg - 25 mg - 25 mg",
"name_nl": "Odefsey 200 mg - 25 mg - 25 mg",
"amp_code": "SAM502497-00",
"strengths": [
"200.0000",
"25.0000",
"25.0000",
"189.8000"
],
"pack_count": 4,
"substances": [
"Emtricitabine",
"Rilpivirine Hydrochloride",
"Rilpivirine",
"Tenofovir Alafenamide Fumarate",
"Tenofovir Alafenamide",
"Lactose",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Emtricitabine, Tenofovir Alafenamide and Rilpivirine",
"authorisation_numbers": [
"EU/1/16/1112/001",
"EU/1/16/1112/002"
]
}See everything about emtricitabine, tenofovir alafenamide and rilpivirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.